Prospects of BRAF/MEK Inhibitor Therapy in Papillary Craniopharyngiomas with the BRAF V600E Mutation: A Scoping Review
Craniopharyngiomas are locally aggressive, rare tumors that pose significant treatment challenges and often result in permanent neurological deficits. Since the discovery of the BRAF V600E driver mutation in papillary craniopharyngioma, several case reports have reported on the efficacy of BRAF inhi...
Saved in:
| Main Authors: | Shingo FUJIO, Rafi ILMANSYAH, Ryutaro MAKINO, Tareq JURATLI, Jun SUGATA, Yuriz BAKHTIAR, Ryosuke HANAYA |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Japan Neurosurgical Society
2025-05-01
|
| Series: | Neurologia Medico-Chirurgica |
| Subjects: | |
| Online Access: | https://www.jstage.jst.go.jp/article/nmc/65/5/65_2024-0246/_pdf/-char/en |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Promising response to vemurafenib and cobimetinib treatment for BRAF V600E mutated craniopharyngioma: a case report and literature review
by: Nina Yu, et al.
Published: (2024-12-01) -
Novel therapy: Combined BRAF and MEK inhibitors for locally advanced BRAF V600L–Positive mucosal melanoma in hypopharynx
by: Sivakamavalli Jeyachandran
Published: (2024-06-01) -
Discordant Response to Nivolumab Plus Ipilimumab and Identification of BRAF V600E Mutation in Biphasic Malignant Pleural Mesothelioma: Case Report
by: Olivia Wilkins, DO, et al.
Published: (2025-05-01) -
SÍNDROME SARCOIDOSIS-LIKE EN UNA MUJER DE 44 AÑOS CON MELANOMA ESTADIO AVANZADO TRATADA CON INHIBIDORES DE BRAF Y MEK. REPORTE DE UN CASO.
by: Juan Gabriel Sánchez Cano, et al.
Published: (2025-04-01) -
The safety and efficacy of dabrafenib plus trametinib for patients with brain metastatic melanoma: a systematic review and meta-analysis
by: Mohammad Amin Habibi, et al.
Published: (2025-06-01)